Morphine-potentiated agonist-induced platelet aggregation through α2-adrenoceptors in human platelets

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 5, 2002, Pages 743-750

  Sheu, Joen Rong ^a   Yeh, Geng Chang ^a   Fang, Chiao Ling ^a   Lin, Chien Huang ^a   Hsiao, George ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adrenoceptors; cAMP; Morphine; Platelet aggregation; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; CALCIUM; COLLAGEN; CYCLIC AMP; FLUORESCEIN ISOTHIOCYANATE; FURA 2 ACETOXYMETHYL ESTER; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; MORPHINE; NITRATE; PROSTAGLANDIN E1; THROMBOXANE B2; TRIFLAVIN; YOHIMBINE;

ARTICLE; BRADYCARDIA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; HUMAN CELL; HYPOTENSION; PRIORITY JOURNAL; SYNCOPE; THROMBOCYTE AGGREGATION; THROMBOSIS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; BLOOD PLATELETS; COLLAGEN; CYCLIC AMP; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; MORPHINE; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0036873528     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200211000-00012     Document Type: Article

References (23)

1. Johnson MW, Mitch WE, Wilcox CS. The cardiovascular actions of morphine and the endogenous opioid peptides. Prog Cardiovasc Dis 1985;27:435-50.
2. Alderman EL, Barry WH, Graham AF, et al. Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med 1972;207:623-7.
3. 1-mediated inhibition of human platelet aggregation. Nature 1975;256:56-7.
4. Collier HO, Roy AC. Hypothesis: Inhibition of prostaglandin-sensitive adenyl cyclase as the mechanism of morphine analgesia. Prostaglandins 1974;7:361-76.
5. 2-adrenoceptors. Eur J Pharmacol 1992;227:349-51.
6. Sheu JR, Lee CR, Lin CC, et al. The antiplatelet activity of PMC, a potent α-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. Br J Pharmacol 1999;127: 1206-12.
7. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95.
8. Sheu JR, Teng CM, Huang TF, Triflavin, an RGD-containing antiplatelet peptide, binds to GP IIIa of ADP-stimulated platelets. Biochem Biophys Res Commun 1992; 189:1236-42.
9. Sheu JR, Hung WC, Wu CH, et al. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation 1999;99:3056-62.
10. Sheu JR, Lin CH, Peng CH, et al. Triflavin, an Arg-GlyAsp-containing peptide, inhibits the adhesion of tumor cells to matrix protein via binding to multiple integrin receptors expressed on human hepatoma cells. Proc Soc Exp Biol Med 1996;213:71-9.
11. 2+ induces with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
12. Karniguian A, Legrand YJ, Caen JP. Prostaglandins: Specific inhibition of platelet adhesion to collagen and relationship with cyclic AMP level. Prostaglandins 1982;23: 437-57.
13. Sheu JR, Hung WC, Kan YC, et al. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol 1998;103: 29-38.
14. Kaji H, Chihara K, Minamitani N, et al. Effect of various catecholamine antagonists on prolactin secretion in conscious male rabbits. Proc Soc Exp Biol Med 1985;180: 144-8.
15. Matos FF, Rollema H, Taiwo YO, et al. Relationship between analgesia and extracellular morphine in brain and spinal cord in aware rats. Brain Res 1995;693:187-95.
16. Charo IF, Feinman RD, Detwiler TC. Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem Biophys Res Commun 1976;72:1462-7.
17. 2-adrenoceptor responses of rat amygdaloid neurons: Co-localization and interactions during withdrawal. J Neurosci 1985;5:3016-24.
18. 2-adrenoceptors attenuates the inhibitory effect of μ opioid receptor agonist on noradrenaline release from brain slices. Naunyn Schmiedebergs Arch Pharmacol 1986;333:377-80.
19. van Willigen G, Donath J, Lapetina EG, et al. Identification of alpha-subunits of trimeric GTP-binding proteins in human platelets by RT-PCR. Biochem Biophys Res Commun 1995;214:254-62.
20. 2+ in platelets is controlled by cyclic AMP: Antagonism between stimulators and inhibitors of adenylate cyclase. Biochem Biophys Res Commun 1984;120:579-85.
21. Fecho K, Maslonek KA, Dykstra LA, et al. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced immunomodulation. Adv Exp Med Biol 1995;373:149-53.
22. Mcdonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med 1996;211:1-6.
23. Murohara T, Parkinson SJ, Waldman SA, et al. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: Role of protein kinase C. Arterioscler Thromb Vas Biol 1995;15:2068-75.